COMMUNIQUÉS West-GlobeNewswire

PALIO and GSW to Operate as Singular Advertising Powerhouse Under GSW Brand

22/01/2018 - 15:15

RALEIGH, N.C., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (NASDAQ: SYNH ), the only fully integrated biopharmaceutical solutions organization, today announced that two of its advertising agencies, PALIO and GSW, [...]

Abattis Partners with Vancouver-Based Craft Brewer to Develop Hemp-Infused, Cannabinoid-Rich, THC-Free Craft Beer

22/01/2018 - 15:02

VANCOUVER, British Columbia, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce the formation of a new partnership (the “ [...]

American Heart Association announces Triangle Life is Why sponsorship with Chiesi USA

22/01/2018 - 15:00

RALEIGH, N.C., Jan. 22, 2018 (GLOBE NEWSWIRE) -- The American Heart Association (AHA) proudly announces Chiesi (key-A-zee), a Cary-based specialty pharmaceutical company, as the first Life is Why sponsor in the Triangle [...]

Enrollment Completed in Randomized Clinical Trial of Habeo™ Cell Therapy for Scleroderma and Impaired Hand Function

22/01/2018 - 15:00

SAN DIEGO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) announces completion of patient enrollment in SCLERADEC II ( NCT02558543 ), a randomized, double-blind, placebo-controlled, parallel [...]

PHM Announces Expansion & Results of Telemedicine Pilot Program; Provides Post-Spinoff Status

22/01/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN CINCINNATI, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]

Patient Growth Equals Big Data for Knalysis Technologies and Canada House Wellness Group

22/01/2018 - 14:39

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies “Knalysis”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV [...]

BioCryst Pharmaceuticals and Idera Pharmaceuticals Announce Merger to Combine Capabilities to Serve More Patients with Rare Diseases

22/01/2018 - 14:30

Filed by BioCryst Pharmaceuticals, Inc. pursuant to Rule 425 Under the Securities Act of 1933 And Deemed Filed Pursuant to Rule 14a-12 Under the Securities Exchange Act of 1934 Subject Company: Idera Pharmaceuticals, [...]

Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura: Study On Schedule for Topline Data this Quarter

22/01/2018 - 14:30

HAYWARD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced a positive outcome of the second, pre-specified interim futility analysis for the RESULT Phase 3 clinical [...]

Cellectar Biosciences to Participate at Noble Capital Markets’ Fourteenth Annual Investor Conference

22/01/2018 - 14:30

MADISON, Wis., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research

22/01/2018 - 14:30

CARLSBAD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based [...]

Lotus Ventures – Closing of Cannabis Financing of $5 Million; Solidifying Expansion Capital

22/01/2018 - 14:30

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 22, 2018 (GLOBE NEWSWIRE) -- The Company has closed its financing for gross proceeds of $5,018, [...]

Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania

22/01/2018 - 14:27

NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc . (NASDAQ: PRPO ), today announced it is collaborating with the cytogenetics laboratory at the University of Pennsylvania to [...]

United Health Products Issues FDA Update

22/01/2018 - 14:15

HENDERSON, Nev., Jan. 22, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTCPK:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]

Inovio Pharmaceuticals' Published Universal Flu Vaccine Data Demonstrates Protective Responses Against All Major, Lethal H1N1 Influenza Viruses From the Last 100 Years in Animal Models

22/01/2018 - 14:00

PLYMOUTH MEETING, Pa., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that Inovio’s synthetic vaccine approach using a collection of synthetic DNA antigens generated broad [...]

PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Increased Its Quarterly Dividend by 25% to $0.25 per Share

22/01/2018 - 14:00

Third Quarter New Order Sales Increased 15.5% Third Quarter Net Income Increased 88% Third Quarter Sales Increased 13.7% DELRAY BEACH, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) today [...]

Sorrento Therapeutics to Present at Noble Capital Markets’ Fourteenth Annual Investor Conference on 01/29/18

22/01/2018 - 14:00

SAN DIEGO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) ("Sorrento"), announced today that it will present at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference at [...]

Altimmune to Participate at the Noble Capital 14th Annual Investor Conference

22/01/2018 - 14:00

GAITHERSBURG, Md., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]

Encouraging Early Safety and Efficacy Data in Cynata’s Phase 1 Trial of CYP-001 in GvHD; DSMB Recommendation to Initiate Enrolment of Second Patient Cohort

22/01/2018 - 14:00

MELBOURNE, Australia, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that the independent Data Safety Monitoring [...]

PositiveID Corporation Announces Lawrence Livermore National Laboratory Evaluation of PositiveID’s FireflyDX

22/01/2018 - 14:00

DELRAY BEACH, Fla., Jan. 22, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR Corporation subsidiary, announced today that [...]